申请人:Boehringer Ingelheim GmbH
公开号:US04224322A1
公开(公告)日:1980-09-23
Compounds of the formula ##STR1## wherein R.sub.1 is unsubstituted, mono-substituted or di-substituted thiomorpholino, where the substituents are selected from the group consisting of methyl, hydroxymethyl, hydroxyl, phenyl and benzyl; R.sub.2 is hydrogen, methyl or benzyl; and R.sub.3 is hydrogen, halogen, alkyl of 1 to 3 carbon atoms or alkoxy of 1 to 3 carbon atoms; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as antiphlogistics and antithrombotics.
式为##STR1##的化合物,其中R.sub.1为未取代、单取代或双取代的硫代吗啉基,所述取代基从甲基、羟甲基、羟基、苯基和苄基中选择;R.sub.2为氢、甲基或苄基;R.sub.3为氢、卤素、1至3个碳原子的烷基或1至3个碳原子的烷氧基;以及其非毒性、药理学上可接受的酸加成盐。这些化合物及其盐可用作抗炎和抗血栓剂。